JAK inhibitors: a promising direction for treating Rheumatoid Arthritis
<p>Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1]. Tumor Necrosis Factor inhibitors (TNFi) promised a new revolutionary era in RA approximately 20 years ago. Since then, different T...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,
2017-06-09.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ijpsdr_000013 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Pelechas Eleftherios |e author |
| 245 | 0 | 0 | |a JAK inhibitors: a promising direction for treating Rheumatoid Arthritis |
| 260 | |b International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, |c 2017-06-09. | ||
| 520 | |a <p>Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1]. Tumor Necrosis Factor inhibitors (TNFi) promised a new revolutionary era in RA approximately 20 years ago. Since then, different TNFi molecules appeared in that direction. Nowadays, clinicians have also added in their armamentarium the first bio similar in order to combat RA. The main question is: do they have achieved their goal regarding their efficacy, and if yes, at what extent?</p> | ||
| 540 | |a Copyright © Pelechas Eleftherios et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Editorial |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ijpsdr.000013 |z Connect to this object online. |